Samsung Bioepis
Manufacturing · South Korea · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
130 Samsung-ro Yeongtong-gu, Suwon-si, G...Phone Number
+82 327280114Website
www.samsungbioepis.comRevenue
$291.2 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
3
1
1
1
1
1
About Samsung Bioepis
Samsung Bioepis specializes in the development of biosimilars, focusing on innovative biopharmaceutical products. The company is dedicated to advancing research and development in the field of biotechnology, aiming to provide high-quality and affordable treatment options. Their intended clients include healthcare providers and patients seeking effective therapies. Samsung Bioepis collaborates with various partners to enhance its product pipeline and expand its market reach.Explore more
Samsung Bioepis Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Samsung Bioepis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Samsung Bioepis launches new products
Congratulate Masked Content for being promoted to Masked Content at Samsung Bioepis
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Samsung Bioepis has new funding data
Check if Samsung Bioepis has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Samsung Bioepis recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Samsung Bioepis is spiking on competitors!
Samsung Bioepis, which may be a good buyer, showed buying intent in Masked Content Topic
Click to see if Samsung Bioepis had a recent Job posting/layoffs
Recommended Actions
Find VP level buyers at Samsung Bioepis
Find more new buyers
Company Profile Activity
Activity Insights
Samsung Bioepis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Samsung Bioepis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Samsung Bioepis.
Samsung Bioepis Tech Stack
A closer look at the technologies used by Samsung Bioepis
Most Recent Scoops
Project
Intellectual Property, Lawsuits, Legal Affairs, Settlement, Pharmaceuticals
Project
Intellectual Property, Lawsuits, Legal Affairs, Settlement
Lateral Move
Executive Move
Executive Moves, Lateral Move
Promotion
Executive Move
Executive Moves, Promotion
Lateral Move
Executive Move
Executive Moves, Lateral Move
Samsung Bioepis News & Media
Samsung Bioepis, Regeneron reach settlement on aflibercept biosimilar - Healio
Under the terms of a settlement and license agreement with Regeneron, Samsung Bioepis will be able to launch Opuviz in the U.S. in January 2027, according to a press release.“As with ranibizumab biosimilars, aflibercept biosimilars have the potential to significantly improve accessibility and affordability for patients,” Thomas Newcomer, vice president and head of U.S. commercialSamsung Bioepis Expands into New Drug Development | DBR - 동아비즈니스리뷰
Establishing a subsidiary for 'platform technology development'Focusing on strengthening the differentiation of new drug technology"Maximizing synergy among the three bio companies"Samsung Bioepis releases Q3 2025 U.S. Biosimilar Market Report
In Q2, the FDA approved two biosimilars in the ustekinumab and bevacizumab markets and four biosimilars were launched within the denosumab and eculizumab markets.Samsung Bioepis inks deal with Harrow for commercialization of ophthalmology biosimilars portfolio
The commercial license will become effective upon completion of the transition of commercial rights from Biogen back to Samsung Bioepis, which is expected to be completed by the end of 2025.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Samsung Bioepis
Sign Up For FreeTo access detailed company insights
Samsung Bioepis specializes in the development of biosimilars, focusing on innovative biopharmaceutical products. The company is dedicated to advancing research and development in the field of biotechnology, aiming to provide high-quality and affordable treatment options. Their intended clients include healthcare providers and patients seeking effe... Read More
